{"id":11207,"date":"2025-07-27T06:28:02","date_gmt":"2025-07-27T04:28:02","guid":{"rendered":"https:\/\/valintermed.com\/?p=11207"},"modified":"2025-07-27T06:28:02","modified_gmt":"2025-07-27T04:28:02","slug":"semeynaya-gipobetalipoproteinemiya","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/family-hypoglycemia\/","title":{"rendered":"Familial hypobetalipoproteinemia"},"content":{"rendered":"
<\/div>\n

Familial hypobetalipoproteinemia is a rare inherited disorder characterized by low plasma high-density lipoprotein (HDL) levels, which may lead to lipid metabolism disorders and an increased risk of atherosclerosis. The condition is associated with abnormal functioning of proteins involved in lipid metabolism, which in turn may be inherited. Low HDL levels have long been associated with increased cardiovascular disease. The disease has a multi-stage nature: from the presence of predisposing genetic factors to environmental exposure, which makes its study especially important in the context of cardiac health.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n